November, 2015. Huntsville, Ala. — The HudsonAlpha Institute for Biotechnology has received a $100,000 grant from the Jane K. Lowe Charitable Foundation  to help establish a clinical genomics program for patients in Alabama and beyond.

“The Jane K. Lowe Charitable Foundation is excited that our grant will assist HudsonAlpha to bring genomic medicine to our region and to become a leader in this rapidly developing technology,” said Jane K. Lowe board member John Wynn. “During her lifetime, Mrs. Lowe was a generous supporter of medical research. This grant enables our foundation to carry on Mrs. Lowe’s legacy by supporting this innovative approach to patient care.

HudsonAlpha recently recruited five world-renowned faculty investigators specializing in genomic medicine. This November, the Institute will open the world’s first clinic solely for the practice of genomic medicine. HudsonAlpha has also established a fully accredited and certified Clinical Sequencing Laboratory, which can provide clinically-validated and interpreted genomic information for physicians worldwide.

”These funds from the Jane Knight Lowe Foundation help HudsonAlpha welcome five of the world’s best genomic scientists. Working with our existing faculty, they are literally changing medicine,” said Lynne Berry, vice president for advancement at HudsonAlpha.

“From the beginning, the mission of HudsonAlpha’s mission has been to utilize the power of genomics to help improve lives. I can’t think of a better way to do that than to use what we know about the genomic sequence to identify the causes of unknown diseases and help identify new therapies for some of the sickest patients,” said Richard M. Myers, PhD, president and scientific director of HudsonAlpha. “We are deeply grateful to the Jane K. Lowe Foundation for this gift.”

About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a genomic science and applications nonprofit organization. It is a high-volume genomic data producer serving thousands of academic, clinical and commercial clients’ needs. The Institute is a global scientific collaborator valued for its genomic data analysis and interpretation to solve some of the most pressing questions in cancer, undiagnosed childhood genetic disorders, neuropsychiatric disorders, immune-mediated disease, agriculture and public health. Its unique 152 acre campus melds the boundaries between nonprofit scientists, educators and entrepreneurs so that collaboration sparks innovation and growth. To learn more about HudsonAlpha, visit: http://hudsonalpha.org/.

About the Jane K. Lowe Charitable Foundation: Mrs. Lowe perpetuated her generosity by giving most of her estate to the Jane K. Lowe Charitable Foundation. She named Billie R. Smith, W. F. Sanders, Jr., and John R. Wynn Trustees of the Foundation to carry out its charitable purposes and oversee the investments of trust assets. After many years of service to Mrs. Lowe and the Foundation, Mr. Smith retired in 2009. He named his son, Richard J. Smith, as his successor. Each year the Foundation distributes the greater of its net income or 5% of its value, as follows: 60% to six named charities and 40% to charitable organizations selected in the discretion of the Trustees. 

HudsonAlpha Media Contact:

Margetta Thomas
Communications Specialist
256-327-0425
mthomas@hudsonalpha.org